|
Namenda Clinical Trials
1 actively recruiting trial across 1 location
No change since May 2026
Also known as: Memantine
Pipeline
Phase 2/3: 1
Top Sponsors
- Inova Health Care Services1
Indications
- Liver Disease1
- Cirrhosis1
- Liver Cancer1
- Hepatocellular Carcinoma1
- Cancer1
Fairfax, Virginia1 trial
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Schar Cancer Institute
Phase 2/3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.